Daniela Galimberti
#148,820
Most Influential Person Now
Researcher
Daniela Galimberti's AcademicInfluence.com Rankings
Daniela Galimberticomputer-science Degrees
Computer Science
#7675
World Rank
#8079
Historical Rank
Machine Learning
#2914
World Rank
#2950
Historical Rank
Artificial Intelligence
#3209
World Rank
#3256
Historical Rank
Database
#4729
World Rank
#4912
Historical Rank
Download Badge
Computer Science
Daniela Galimberti's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Daniela Galimberti Influential?
(Suggest an Edit or Addition)Daniela Galimberti's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2013) (3484)
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (2011) (2511)
- Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) (1701)
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease (2009) (1476)
- Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) (1230)
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis (2013) (1170)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility (2019) (589)
- APOE and Alzheimer disease: a major gene with semi-dominant inheritance (2011) (528)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis (2015) (420)
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers (2011) (385)
- A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk (2008) (296)
- Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. (2006) (269)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study (2015) (255)
- SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis (2012) (252)
- Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status (2016) (252)
- New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) (246)
- The cornea in Sjogren's syndrome: an in vivo confocal study. (2007) (243)
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. (2008) (227)
- Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease (2006) (213)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2017) (211)
- Consensus guidelines for lumbar puncture in patients with neurological diseases (2017) (197)
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia (2016) (189)
- TREM2 regulates microglial cell activation in response to demyelination in vivo (2015) (188)
- Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease (2006) (185)
- DNA methylation in repetitive elements and Alzheimer disease (2011) (182)
- Convergent genetic and expression data implicate immunity in Alzheimer's disease (2014) (172)
- Circulating miRNAs as potential biomarkers in Alzheimer's disease. (2014) (171)
- Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia (1998) (162)
- Selective DNA Methylation of BDNF Promoter in Bipolar Disorder: Differences Among Patients with BDI and BDII (2012) (160)
- Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis (2011) (157)
- Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study (2018) (139)
- Heterozygous TREM2 mutations in frontotemporal dementia (2014) (139)
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes. (2015) (133)
- A multicentre validation study of the diagnostic value of plasma neurofilament light (2021) (130)
- Corneal involvement in rheumatoid arthritis: an in vivo confocal study. (2008) (130)
- Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis (2013) (129)
- Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study (2019) (128)
- Disease-modifying treatments for Alzheimer’s disease (2011) (125)
- The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients (2015) (116)
- The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility (2017) (113)
- Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation (2013) (111)
- Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients (2003) (110)
- Childhood Absence Epilepsy: Evolution and Prognostic Factors (2005) (110)
- Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. (2020) (110)
- Refining genetic associations in multiple sclerosis (2008) (108)
- Investigation of c9orf72 in 4 neurodegenerative disorders. (2012) (106)
- Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosis (2005) (106)
- Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (2012) (106)
- Plasma levels of beta-amyloid (1–42) in Alzheimer's disease and mild cognitive impairment (2006) (104)
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (2015) (103)
- In vivo confocal microscopy of the ocular surface. (2010) (103)
- Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations (2011) (101)
- IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease (2002) (101)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (98)
- EFNS‐ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease (2015) (98)
- Mutation analysis of CHCHD10 in different neurodegenerative diseases. (2015) (98)
- In vivo confocal microscopy of meibomian glands in Sjögren's syndrome. (2011) (98)
- Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis (2013) (97)
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study (2019) (96)
- Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition (2008) (94)
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome (2018) (94)
- MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers (2012) (92)
- Exosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases (2019) (90)
- Progress in Alzheimer’s disease (2012) (90)
- Optimal Plasma Progranulin Cutoff Value for Predicting Null Progranulin Mutations in Neurodegenerative Diseases: A Multicenter Italian Study (2011) (87)
- Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline. (2010) (86)
- Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease (2016) (86)
- Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2021) (85)
- Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid (2011) (85)
- Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. (2014) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic Mild Cognitive Impairment converted to Alzheimer's disease (2009) (83)
- Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis (2013) (83)
- Disease-modifying drugs in Alzheimer’s disease (2013) (83)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- α-MSH Peptides Inhibit Production of Nitric Oxide and Tumor Necrosis Factor-α by Microglial Cells Activated with β-Amyloid and Interferon γ (1999) (79)
- Epigenetic Modulation of BDNF Gene in Patients with Major Depressive Disorder (2013) (77)
- Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration (2006) (77)
- MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels (2004) (77)
- Pioglitazone for the treatment of Alzheimer’s disease (2017) (76)
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia (2020) (75)
- Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration (2008) (75)
- Old and new acetylcholinesterase inhibitors for Alzheimer’s disease (2016) (73)
- Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients (2011) (72)
- Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients. (2014) (71)
- Physical activity reduces the risk of dementia in mild cognitive impairment subjects: a cohort study. (2014) (71)
- Innate Immune System and Inflammation in Alzheimer's Disease: From Pathogenesis to Treatment (2014) (71)
- Epigenetic Regulation of Fatty Acid Amide Hydrolase in Alzheimer Disease (2012) (70)
- Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis (2013) (70)
- Psychiatric Symptoms in Frontotemporal Dementia: Epidemiology, Phenotypes, and Differential Diagnosis (2015) (69)
- CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. (2015) (68)
- Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation (2009) (68)
- Early onset behavioral variant frontotemporal dementia due to the C9ORF72 hexanucleotide repeat expansion: psychiatric clinical presentations. (2012) (68)
- Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis (2004) (67)
- Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population (2010) (67)
- Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis (2006) (67)
- Faculty Opinions recommendation of Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. (2009) (67)
- Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. (2013) (65)
- Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia (2015) (65)
- New insights on the genetic etiology of Alzheimer’s and related dementia (2020) (64)
- The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia (2014) (63)
- Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer’s Disease (2016) (62)
- From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. (2011) (61)
- Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. (2011) (60)
- Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease. (2009) (59)
- Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration. (2002) (58)
- White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort (2017) (58)
- Inflammation and oxidative damage in Alzheimer's disease: friend or foe? (2011) (58)
- An Emerging Role for Long Non-Coding RNA Dysregulation in Neurological Disorders (2013) (57)
- MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis (2012) (57)
- Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series (2008) (56)
- Shared genetic contribution to ischemic stroke and Alzheimer's disease (2016) (55)
- Role of hnRNP-A1 and miR-590-3p in neuronal death: genetics and expression analysis in patients with Alzheimer disease and frontotemporal lobar degeneration. (2011) (55)
- An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease. (2011) (55)
- The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. (2010) (55)
- The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with β-amyloid protein (2000) (54)
- The Enigmatic Role of Viruses in Multiple Sclerosis: Molecular Mimicry or Disturbed Immune Surveillance? (2017) (54)
- Transcranial Direct Current Stimulation Modulates Cortical Neuronal Activity in Alzheimer's Disease (2016) (54)
- Recognition of viral and self‐antigens by TH1 and TH1/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses (2017) (52)
- Immunotherapy against amyloid pathology in Alzheimer's disease (2013) (52)
- A Functional Variant in ERAP1 Predisposes to Multiple Sclerosis (2012) (51)
- Inflammation in dry eye associated with rheumatoid arthritis: Cytokine and in vivo confocal microscopy study (2013) (50)
- HLA-class I markers and multiple sclerosis susceptibility in the Italian population (2009) (50)
- Novel exon 1 progranulin gene variant in Alzheimer’s disease (2008) (50)
- Efficacy and safety of topiramate in infants according to epilepsy syndromes (2005) (49)
- Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors (2013) (48)
- Progranulin Gene Variability and Plasma Levels in Bipolar Disorder and Schizophrenia (2012) (48)
- Faculty Opinions recommendation of Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. (2011) (48)
- A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia (2015) (46)
- Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study (2017) (46)
- Inflammatory molecules in Frontotemporal Dementia: Cerebrospinal fluid signature of progranulin mutation carriers (2015) (46)
- Treatment of Alzheimer's disease: symptomatic and disease-modifying approaches. (2010) (46)
- MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease (2020) (45)
- Variations of the perforin gene in patients with multiple sclerosis (2008) (44)
- Comparison of arterial spin labeling registration strategies in the multi‐center GENetic frontotemporal dementia initiative (GENFI) (2018) (43)
- Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study (2019) (43)
- In vivo confocal microscopy of conjunctival roundish bright objects: young, older, and Sjögren subjects. (2011) (42)
- Alzheimer's disease: from pathogenesis to disease-modifying approaches. (2011) (42)
- Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia (2013) (42)
- Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Dementia1 (2018) (42)
- Does Vascular Burden Contribute to the Progression of Mild Cognitive Impairment to Dementia? (2012) (42)
- Cerebrospinal fluid biomarkers in Progranulin mutations carriers. (2011) (42)
- The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case–control cohorts (2013) (42)
- Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration (2011) (42)
- Inflammation in neurodegenerative disorders: friend or foe? (2008) (41)
- Replication study to confirm the role of CYP2D6 polymorphism rs1080985 on donepezil efficacy in Alzheimer's disease patients. (2012) (40)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) (40)
- Frontotemporal lobar degeneration: current knowledge and future challenges (2012) (40)
- Fluid biomarkers in frontotemporal dementia: past, present and future (2020) (40)
- Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers (2018) (40)
- Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross‐sectional diffusion tensor imaging study (2018) (39)
- Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study (2018) (39)
- Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia (2020) (38)
- The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression (2012) (38)
- Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients (2014) (38)
- Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease. (2016) (38)
- Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis (2016) (38)
- Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients (2005) (37)
- CSF β-amyloid and white matter damage: a new perspective on Alzheimer’s disease (2017) (36)
- Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects. (2014) (36)
- Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
- Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease. (2016) (36)
- Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism (2015) (36)
- Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis (2017) (36)
- Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up (2016) (35)
- Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system (2004) (35)
- Body Mass Index Predicts Progression of Mild Cognitive Impairment to Dementia (2016) (35)
- Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study (2019) (35)
- Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. (2010) (34)
- C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder (2014) (34)
- Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort (2018) (34)
- The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients (2019) (34)
- Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation. (2016) (34)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2018) (33)
- Heterosexual Pedophilia in a Frontotemporal Dementia Patient with a Mutation in the Progranulin Gene (2011) (33)
- Association of a NOS1 promoter repeat with Alzheimer's disease (2008) (33)
- Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions (2014) (33)
- Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry. (2019) (33)
- Pin1 Contribution to Alzheimer’s Disease: Transcriptional and Epigenetic Mechanisms in Patients with Late-Onset Alzheimer’s Disease (2012) (33)
- A novel network analysis approach reveals DNA damage, oxidative stress and calcium/cAMP homeostasis-associated biomarkers in frontotemporal dementia (2017) (32)
- Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study (2018) (32)
- Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression (2020) (32)
- Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma. (1999) (32)
- Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders (2014) (32)
- Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters (2021) (31)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (31)
- Electroencephalographic and Epileptic Patterns in X Chromosome Anomalies (2004) (31)
- CCR2-64I polymorphism and CCR5Δ32 deletion in patients with Alzheimer's disease (2004) (31)
- Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia (2019) (31)
- ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer’s disease[S] (2019) (31)
- Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia (2019) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia (2021) (30)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Possible association between SNAP-25 single nucleotide polymorphisms and alterations of categorical fluency and functional MRI parameters in Alzheimer's disease. (2014) (30)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease (2006) (29)
- The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration (2009) (29)
- Progranulin gene (GRN) promoter methylation is increased in patients with sporadic frontotemporal lobar degeneration (2013) (29)
- Repetitive element hypermethylation in multiple sclerosis patients (2016) (29)
- Drusen-like Deposits in Young Adults Diagnosed With Systemic Lupus Erythematosus. (2017) (28)
- GRN variability contributes to sporadic frontotemporal lobar degeneration. (2010) (28)
- A Trans-Specific Polymorphism in ZC3HAV1 Is Maintained by Long-Standing Balancing Selection and May Confer Susceptibility to Multiple Sclerosis (2012) (28)
- Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis (2014) (28)
- The Role of the Innate Immune System in Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Eye on Microglia (2013) (28)
- Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis (2008) (28)
- Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging (2020) (28)
- ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution (2007) (27)
- CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis (2017) (27)
- The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint (2019) (27)
- A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia (2011) (26)
- Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease (2019) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (2021) (26)
- Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes (2018) (26)
- Differential early subcortical involvement in genetic FTD within the GENFI cohort (2021) (26)
- Interleukin-6 plasma level increases with age in an Italian elderly population (“The Treviso Longeva”–Trelong–study) with a sex-specific contribution of rs1800795 polymorphism (2009) (26)
- LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients (2018) (26)
- Synergistic effect of beta-amyloid protein and interferon gamma on nitric oxide production by C2C12 muscle cells. (2000) (26)
- Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation (2017) (26)
- Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result (2018) (26)
- Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes (2019) (25)
- Analysis of genes, pathways and networks involved in disease severity and age at onset in primary-progressive multiple sclerosis (2015) (25)
- The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment (2007) (24)
- White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study (2019) (24)
- Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes (2010) (24)
- Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population (2007) (24)
- Intra-arterial chemotherapy with melphalan for intraocular retinoblastoma (2013) (24)
- Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration (2007) (23)
- Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease (2019) (23)
- IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment (2020) (23)
- IP‐10 serum levels are not increased in mild cognitive impairment and Alzheimer's disease (2007) (23)
- Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer's disease: genetics and expression analysis. (2011) (23)
- Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. (2008) (23)
- Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology (2020) (23)
- Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort (2020) (23)
- Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (2012) (22)
- Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? (2019) (22)
- MDC/CCL22 intrathecal levels in patients with multiple sclerosis (2008) (22)
- Hypermethylation of the CpG-island near the C 9 orf 72 G 4 C 2-repeat expansion in FTLD patients (2014) (22)
- The T-786C NOS3 polymorphism in Alzheimer's disease: Association and influence on gene expression (2005) (22)
- Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation. (2016) (22)
- Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes (2020) (22)
- A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy (2008) (22)
- Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration (2007) (21)
- CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course (2007) (21)
- Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor (2017) (21)
- Genetics of Frontotemporal Lobar Degeneration (2012) (21)
- Education modulates brain maintenance in presymptomatic frontotemporal dementia (2019) (21)
- CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia (2018) (20)
- Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder. (2014) (20)
- Is HCRTR2 a Genetic Risk Factor for Alzheimer's Disease? (2014) (20)
- The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment. (2010) (20)
- CSF β-amyloid predicts prognosis in patients with multiple sclerosis (2018) (20)
- Clinical phenotypes and genetic biomarkers of FTLD (2012) (20)
- Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration (2020) (20)
- Production of IL-6 by human myoblasts stimulated with Aβ (2001) (20)
- Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol. (2016) (19)
- Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (2016) (19)
- Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males (2010) (19)
- Study of thyroid hormone receptor alpha gene polymorphisms on Alzheimer's disease (2011) (19)
- Novel CSF biomarkers to discriminate FTLD and its pathological subtypes (2018) (19)
- A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. (2013) (19)
- Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis (2011) (19)
- Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study. (2013) (18)
- Gene promoter methylation and expression of Pin1 differ between patients with frontotemporal dementia and Alzheimer's disease (2016) (18)
- Association of neuronal nitric oxide synthase C276T polymorphism with Alzheimer’s disease (2005) (18)
- Chemokine network in multiple sclerosis: role in pathogenesis and targeting for future treatments (2004) (18)
- Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review (2017) (18)
- Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis (2010) (18)
- Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative (2020) (18)
- Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? (2015) (18)
- CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease. (2004) (17)
- Novel evidence of phenotypical variability in the hexanucleotide repeat expansion in chromosome 9. (2013) (17)
- Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism. (2013) (17)
- Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment. (2012) (17)
- Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia (2019) (17)
- No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort (2011) (17)
- A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia (2021) (17)
- A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort (2020) (17)
- Candidate gene analysis of IP-10 gene in patients with Alzheimer's disease (2006) (17)
- GSK3β genetic variability in patients with Multiple Sclerosis (2011) (17)
- E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis (2005) (17)
- Role of VEGF gene variability in longevity: A lesson from the Italian population (2008) (17)
- A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation (2012) (16)
- Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia. (2013) (16)
- Profiling of Ubiquitination Pathway Genes in Peripheral Cells from Patients with Frontotemporal Dementia due to C9ORF72 and GRN Mutations (2015) (16)
- Evidence of predisposing epimutation in retinoblastoma (2018) (16)
- Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer’s disease (2009) (16)
- Clinical and MRI correlates of disease progression in a case of nonfluent/agrammatic variant of primary progressive aphasia due to progranulin (GRN) Cys157LysfsX97 mutation (2014) (16)
- CHCHD 10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis (2015) (16)
- Ventricular volume expansion in presymptomatic genetic frontotemporal dementia (2019) (16)
- Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies. (2011) (16)
- Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder. (2019) (16)
- A study of the association between the ADAM12 and SH3PXD2A (SH3MD1) genes and Alzheimer's disease (2010) (15)
- Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. (2022) (15)
- Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans (2012) (15)
- Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia (2019) (15)
- GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype. (2013) (15)
- Comparison of β2-microglobulin serum level between Alzheimer’s patients, cognitive healthy and mild cognitive impaired individuals (2018) (15)
- CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients. (2016) (15)
- APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias. (2010) (15)
- Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers (2020) (15)
- Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort (2019) (15)
- Serotonin Transporter Gene Polymorphic Element 5-HTTLPR Increases the Risk of Sporadic Parkinson’s Disease in Italy (2009) (15)
- Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers (2018) (15)
- The Neuroanatomy of Somatoform Disorders: A Magnetic Resonance Imaging Study. (2019) (14)
- Disruption of brainstem monoaminergic fibre tracts in multiple sclerosis as a putative mechanism for cognitive fatigue: a fixel-based analysis (2021) (14)
- MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. (2009) (14)
- BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease. (2011) (14)
- PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population. (2016) (14)
- The CST3 B haplotype is associated with frontotemporal lobar degeneration (2010) (14)
- SORL1 Gene is Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease. (2015) (14)
- Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population (2010) (13)
- Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (2020) (13)
- Lacunar thalamic infarcts and amnesia. (1989) (13)
- Idalopirdine as a treatment for Alzheimer’s disease (2015) (13)
- Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis (2016) (13)
- New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (2021) (13)
- P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis (2005) (13)
- Detailed stratified GWAS analysis for severe COVID-19 in four European populations (2022) (13)
- Emerging amyloid disease-modifying drugs for Alzheimer’s disease (2016) (13)
- The distinct roles of monoamines in multiple sclerosis: A bridge between the immune and nervous systems? (2021) (13)
- SELPLG and SELP single-nucleotide polymorphisms in multiple sclerosis (2006) (13)
- Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study (2018) (13)
- CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration (2020) (13)
- Progress in Alzheimer’s disease research in the last year (2013) (12)
- Progranulin as a therapeutic target for dementia (2018) (12)
- The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design (2016) (12)
- Mesenteric-portal Vein Thrombosis in a Patient with Hyperhomocysteinemia and Heterozygous for 20210A Prothrombin Allele (2000) (12)
- The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances. (2009) (12)
- Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects (2011) (11)
- Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study (2020) (11)
- PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline. (2018) (11)
- Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis (2019) (11)
- Non-progressive leukoencephalopathy with bilateral anterior temporal cysts: a case report and review of the literature (2005) (11)
- Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia (2021) (11)
- Experimental Vitreous Replacement with Perfluorophenanthrene (1997) (11)
- Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling (2021) (11)
- Sciatic endometriosis presenting as periodic (catamenial) sciatic radiculopathy (2012) (11)
- Absence of TARDBP Gene Mutations in an Italian Series of Patients with Frontotemporal Lobar Degeneration (2009) (11)
- Candidate gene analysis of semaphorins in patients with Alzheimer’s disease (2010) (11)
- Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study (2021) (11)
- T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients (2020) (11)
- Diagnostic value of plasma neurofilament light: A multicentre validation study (2020) (11)
- Serum folate concentrations in patients with cortical and subcortical dementias (2007) (11)
- Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration? (2010) (10)
- The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype. (2012) (10)
- Two‐point‐NGS analysis of cancer genes in cell‐free DNA of metastatic cancer patients (2020) (10)
- Failure to replicate an association of rs5984894 SNP in the PCDH11X gene in a collection of 1,222 Alzheimer's disease affected patients. (2010) (10)
- Progressive, isolated language disturbance: Its significance in a 65-year-old-man. A case report with implications for treatment and review of literature (2006) (10)
- Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease (Molecular Psychiatry (2013) 18 (521) DOI: 10.1038/mp.2012.75)) (2013) (10)
- Community study of fixed-combination adapalene 0.1% and benzoyl peroxide 2.5% in acne. (2010) (10)
- Alpha1-antichymotrypsin induces TNF-α production and NF-κB activation in the murine N9 microglial cell line (2009) (10)
- C9ORF72 repeat expansion not detected in patients with multiple sclerosis (2014) (10)
- The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia. (2015) (10)
- Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform (2019) (10)
- Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes. (2017) (10)
- Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration (2022) (10)
- Polymorphisms in the LOC387715/ARMS2 Putative Gene and the Risk for Alzheimer’s Disease (2008) (9)
- CCL8/MCP-2 association analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration (2009) (9)
- Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort (2020) (9)
- Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia. (2012) (9)
- SNARE Complex Polymorphisms Associate with Alterations of Visual Selective Attention in Alzheimer's Disease. (2019) (9)
- Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy (2008) (9)
- Genetics and neurobiology of frontotemporal lobar degeneration (2006) (9)
- Candidate gene analysis of selectin cluster in patients with multiple sclerosis (2009) (9)
- Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detection (2022) (9)
- Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations. (2016) (9)
- Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion of melphalan. (2013) (9)
- A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study (2021) (8)
- The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases (2022) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- Epilepsy and Electroencephalographic Findings in Pericentric Inversion of Chromosome 12 (2004) (8)
- Differences in Sex Distribution Between Genetic and Sporadic Frontotemporal Dementia (2021) (8)
- Comparison of Hodgkin’s Lymphoma in Children and Adolescents. A Twenty Year Experience with MH’96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols (2020) (8)
- Typical absence seizures associated with localization-related epilepsy: A clinical and electroencephalographic characterization (2005) (8)
- Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study (2021) (8)
- Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy (2018) (7)
- Is the ornithine transcarbamylase gene a genetic determinant of Alzheimer’s disease? (2009) (7)
- [Left atrial thrombosis in patients with antiphospholipid antibody syndrome and mesenchymal abnormal septum]. (2001) (7)
- MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia (2021) (7)
- Disease-related cortical thinning in presymptomatic granulin mutation carriers (2020) (7)
- Rapidly progressive primary progressive aphasia and parkinsonism with novel GRN mutation (2017) (7)
- Balò’s concentric sclerosis: still to be considered as a variant of multiple sclerosis? (2015) (7)
- Self-Awareness for Memory Impairment in Amnestic Mild Cognitive Impairment: A Longitudinal Study (2017) (7)
- Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy (2015) (7)
- Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis (2014) (7)
- Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia (2022) (7)
- The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort (2021) (7)
- Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis (2007) (7)
- Interaction between the APOE ɛ4 allele and the APH-1b c+651T>G SNP in Alzheimer's disease (2008) (7)
- Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease (2020) (7)
- CIRCULATING AND INTRATHECAL MIRNAS AS POTENTIAL BIOMARKERS FOR ALZHEIMER'S DISEASE (2014) (6)
- Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? (2017) (6)
- The functional MAOA‐uVNTR promoter polymorphism in patients with frontotemporal dementia (2008) (6)
- Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration. (2012) (6)
- Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis. (2019) (6)
- Extracellular Vesicles in Multiple Sclerosis: Role in the Pathogenesis and Potential Usefulness as Biomarkers and Therapeutic Tools (2021) (6)
- A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status. (2016) (6)
- Retinoblastoma Is Characterized by a Cold, CD8+ Cell Poor, PD-L1− Microenvironment, Which Turns Into Hot, CD8+ Cell Rich, PD-L1+ After Chemotherapy (2021) (6)
- The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases. (2020) (6)
- Behavioral genetics of neurodegenerative disorders. (2012) (6)
- Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia (2020) (6)
- A Novel Study and Meta-Analysis of the Genetic Variation of the Serotonin Transporter Promoter in the Italian Population Do Not Support a Large Effect on Alzheimer's Disease Risk (2011) (6)
- Estimating the inheritance of frontotemporal lobar degeneration in the Italian population. (2014) (6)
- Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation (2022) (6)
- [Argentine guidelines for urticaria and angioedema]. (2014) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion: a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits. (2014) (5)
- Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort (2021) (5)
- Exome sequencing identifies rare damaging variants in the ATP8B4 and ABCA1 genes as novel risk factors for Alzheimer’s Disease (2020) (5)
- Oral verrucous carcinoma treated with carbon dioxide laser (2009) (5)
- Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy (2015) (5)
- Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes. (2016) (5)
- MRI Helps Depict Clinically Undetectable Risk Factors in Advanced Stage Retinoblastomas (2015) (5)
- The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis (2022) (5)
- Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage (2022) (5)
- Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia (2018) (5)
- Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease. (2008) (5)
- New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab (2020) (5)
- Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease (2022) (5)
- Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia (2022) (4)
- A case of primary erythromelalgia (2009) (4)
- Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease (2021) (4)
- Cerebrospinal fluid glutamate changes in functional movement disorders (2020) (4)
- Frequency of the Chromosome 9 C9ORF72 Hexanucleotide Repeats in Italian Patients with Frontotemporal Lobar Degeneration (2012) (4)
- White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers (2020) (4)
- Transmembrane protein 106B gene (TMEM106B) variability and influence on progranulin plasma levels in patients with Alzheimer's disease. (2014) (4)
- Diogenes syndrome in dementia: a case report (2021) (4)
- Temporal order of clinical and biomarker changes in familial frontotemporal dementia (2022) (4)
- CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis. (2019) (4)
- Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis (2022) (4)
- Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis (2021) (4)
- C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts (2020) (4)
- Case Report: Efficacy of Rituximab in a Patient With Familial Mediterranean Fever and Multiple Sclerosis (2021) (4)
- Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia. (2016) (4)
- Global network structure and local transcriptomic vulnerability shape atrophy in sporadic and genetic behavioral variant frontotemporal dementia (2021) (4)
- Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? (2021) (4)
- miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis (2022) (4)
- Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer’s Disease Spectrum: Who Really Deserves an A+? (2021) (3)
- Genetic risk factors for posterior cortical atrophy (2015) (3)
- C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone (2020) (3)
- Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients (2022) (3)
- Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset. (2019) (3)
- SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA (2017) (3)
- Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience. (2021) (3)
- Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study (2022) (3)
- Consensus guidelines to perform lumbar puncture for CSF sampling in patients with neurological conditions (2015) (3)
- New insights on ocular surface disease in patients with atopic dermatitis treated with dupilumab (2021) (3)
- Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study (2021) (3)
- Late‐onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation (2020) (3)
- Role of Chitinase 3–like 1 as a Biomarker in Multiple Sclerosis (2022) (3)
- Data‐driven staging of genetic frontotemporal dementia using multi‐modal MRI (2022) (3)
- Overlap Between Frontotemporal Dementia and Dementia with Lewy Bodies: A Treviso Dementia (TREDEM) Registry Case Report. (2019) (3)
- Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy. (2014) (3)
- Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer’s disease and longevity in an Italian population (2021) (3)
- Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition. (2021) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers. (2022) (3)
- Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu‐Hakola Disease (2019) (3)
- Brain temperature in multiple sclerosis (2014) (3)
- Merkel cell carcinoma in a patient with relapsing-remitting multiple sclerosis treated with fingolimod (2017) (2)
- GENFI - The GENetic Frontotemporal dementia Initiative (2012) (2)
- New Perspectives for the Treatment of Alzheimer's Disease (2008) (2)
- Cognitive composites for genetic frontotemporal dementia: GENFI-Cog (2021) (2)
- Synchronous malignant transformation of bilateral symmetrical retinocytoma (2013) (2)
- Frontotemporal Lobar Degeneration (2015) (2)
- Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab (2022) (2)
- Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia (2022) (2)
- Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer’s disease (2021) (2)
- FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration. (2010) (2)
- Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia (2022) (2)
- A Critical Review on Structural Neuroimaging Studies in BD: a Transdiagnostic Perspective from Psychosis to Fronto-Temporal Dementia (2020) (2)
- A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype ɛ4/ɛ4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report. (2019) (2)
- P3-219: Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: Functional and phenotypic correlations (2008) (2)
- Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysis. (2021) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Binge eating and fast cognitive worsening in an early-onset bvFTD patient carrying C9ORF72 expansion (2015) (2)
- Frontotemporal Dementia Misdiagnosed for Post-Treatment Lyme Disease Syndrome or vice versa? A Treviso Dementia (TREDEM) Registry Case Report. (2018) (1)
- Disease-modifying drugs in multiple sclerosis: new oral options (2012) (1)
- Progranulin genetic variability in primary progressive multiple sclerosis (2009) (1)
- From brain volumes to subgroup classification in genetic mutation carriers for frontotemporal dementia: A cluster analysis in the GENFI study (2021) (1)
- CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia (2022) (1)
- Genetics and molecular biology of Alzheimer's disease and frontotemporal lobar degeneration (2010) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- Faculty Opinions recommendation of Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort. (2012) (1)
- 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay (2021) (1)
- Alzheimer's disease: From pathogenesis to novel therapeutic approaches (2009) (1)
- Use of evolocumab in a patient with homozygous familial hypercholesterolemia (2017) (1)
- Progress in multiple sclerosis research in the last year (2012) (1)
- Predicting multiple sclerosis: a large international multicentre study (2015) (1)
- Screening of CHCHD10 in an Italian cohort of ALS/ALS-FTD patients (P2.051) (2015) (1)
- Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome. (2020) (1)
- Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations (2022) (1)
- The CBI‐R detects early behavioural impairment in genetic frontotemporal dementia (2022) (1)
- Psychiatric Disorders in Alzheimer Disease With the Presenilin-1 L226F Mutation (2020) (1)
- Selective DNA methylation of BDNF promoter and nociceptin gene in bipolar disorder (2011) (1)
- Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort (2022) (1)
- Protective effects of HLA-DRB1*04 subtypes in Parkinson's and Alzheimer's diseases implicate acetylated Tau PHF6 sequences (2021) (1)
- Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia (2021) (1)
- MULTIPLE DISTINCT ATROPHY PATTERNS FOUND IN GENETIC FRONTOTEMPORAL DEMENTIA USING SUBTYPE AND STAGE INFERENCE (SUSTAIN) (2017) (1)
- Intraocular and plasma kinetics of tenoxicam in rabbits (1993) (1)
- Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: applied to GENFI study (2018) (1)
- across RNA cell death gene networks is implicated in the semantic variant of primary progressive aphasia. (2019) (1)
- Subtype and stage inference identifies distinct atrophy patterns in genetic frontotemporal dementia that MAP onto specific MAPT mutations (2020) (1)
- Frontotemporal Lobar Degeneration: Genetics and Clinical Phenotypes (2014) (1)
- Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia (2022) (1)
- In vivo evidence of functional disconnection between brainstem monoaminergic nuclei and brain networks in multiple sclerosis. (2021) (1)
- Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study. (2021) (1)
- No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis (2014) (1)
- Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration. (2011) (1)
- Osteopontin gene variations protect against multiple sclerosis development and evolution (2007) (1)
- Phenotypic heterogeneity of the GRN ASP22ffs mutation in a large Italian kindred (2011) (1)
- Solid Lipid Nanoparticles Topically Administered in Rabbits as New Drug Delivery System: A Preliminary Study of Safety and Bioavailability (2009) (1)
- More Atypical than Atypical Alzheimer’s Disease Phenotypes: A Treviso Dementia (TREDEM) Registry Case Report (2021) (1)
- Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort (2022) (1)
- Data-driven algorithm for the diagnosis of behavioral variant frontotemporal dementia (2019) (1)
- Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients. (2018) (1)
- MULTIPLE DISTINCT ATROPHY PATTERNS FOUND IN GENETIC FRONTOTEMPORAL DEMENTIA USING SUBTYPE AND STAGE INFERENCE (SUSTAIN) (2017) (1)
- Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry. (2020) (1)
- Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study (2021) (1)
- Investigation on DNA methylation status of opioid peptides promoters in PBMCs of subjects with bipolar disorder (2011) (1)
- Differentiating Vogt-Koyanagi-Harada syndrome from recurrent optic neuritis: a case report and review of the literature concerning Hispanic patients (2017) (1)
- Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 (2022) (0)
- The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study (2023) (0)
- Early-onset dementia with presenilin-1 mutationand motor abnormalities in an Italian patient : a case report (2011) (0)
- Multimodal imaging analysis of C9orf72-associated FTD in the Genetic Frontotemporal dementia Initiative (GENFI) study (2016) (0)
- Phenotypic heterogeneity of the rare R377W PSEN1 mutation: Late‐onset presentation with mixed Alzheimer’s and frontotemporal dementia features (2020) (0)
- P3-025 Oxidative imbalance as potential biological marker for Alzheimer's disease (2004) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- Faculty Opinions recommendation of A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease. (2009) (0)
- EARLY REGIONAL HYPOMETABOLISM IN PRE-SYMPTOMATIC CARRIERS OF MAPT: A GENFI SUB-STUDY (2019) (0)
- Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia (2022) (0)
- The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort (2020) (0)
- SQSTM1 gene mutations in the Frontotemporal Lobar Degeneration/ Amyotrophic Lateral Sclerosis spectrum (2012) (0)
- Possible left endoventricular myxoma in a patient with deep vein thrombosis of the lower limbs: a case report (2013) (0)
- Expression of a membrane-bound and solubile form of TREM-2 in the central nervous system: association with multiple sclerosis (2007) (0)
- Faculty Opinions recommendation of Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. (2012) (0)
- Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia. (2022) (0)
- Frequency of the chromosome 9 hexanucleotide repeat expansion in Italian patients with frontotemporal lobar degeneration (2012) (0)
- Elderly patients treated with oral anticoagulant: a prospective cohort study (1999) (0)
- Lag-time as a plasmatic oxidative stress marker associated with apoe4 carrier status in Alzheimer's disease patients (2019) (0)
- Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer’s disease (2011) (0)
- A data‐driven disease progression model of fluid biomarkers in genetic FTD (2021) (0)
- Carotid endarterectomy and cognitive function in patients without cognitive impairment at baseline: a longitudinal study (2006) (0)
- 2019IL-33 and its decoy sST2 in patients with Alzheimer’s Disease and Mild Cognitive Impairment (2019) (0)
- Trajectory of apathy, cognition and neural correlates in the decades before symptoms in frontotemporal dementia (2020) (0)
- Genetic and functional analysis of progranulin gene variants in Alzheimer's disease (2008) (0)
- WHITE MATTER HYPERINTENSITIES IN GENETIC FRONTOTEMPORAL DEMENTIA: A GENFI STUDY (2017) (0)
- Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study (2023) (0)
- The inner fl uctuations of the brain in presymptomatic Frontotemporal Dementia : The chronnectome fi ngerprint (2019) (0)
- Intrathecal chemochine levels in cortical lobar degenerations (2005) (0)
- Genetic analysis of the 5HTTLPR polymorphism in Alzheimer’s disease and frontotemporal dementia (2006) (0)
- Cerebrospinal fluid biomarkers in patients carrying delCACT mutation in exon 8 of Progranulin gene: report of 10 Italian cases (2010) (0)
- Effect of fi ngolimod treatment on circulating miR-15 b , miR 23 a and miR-223 levels in patients with multiple sclerosis (2017) (0)
- Autosomal Dominant Frontotemporal Lobar Degeneration: From Genotype to Phenotype (2018) (0)
- Trombosi atriale destra in paziente con sindrome da anticorpi antifosfolipidi e setto anomalo mesenchimale (2001) (0)
- [Kawasaki syndrome]. (1989) (0)
- Polymorphism of the hypocretin system genes and Alzheimer’s disease: association study in an Italian population (2010) (0)
- P.2.f.002 Selective DNA methylation of BDNF promoter in bipolar disorder (2010) (0)
- Presenelin-1 mutation E318G in the Italian population (2006) (0)
- P-699 - Selective DNA Methylation of Bdnf Promoter in Bipolar Disorder: Differences Among Patients vs Controls and Potential Influence of Pharmacological Treatments (2012) (0)
- Differences in sex distribution between genetic and sporadic FTD (2021) (0)
- Faculty Opinions recommendation of Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. (2011) (0)
- CROSS-SECTIONAL STUDIES OF PLASMA PROTEOMIC BIOMARKERS RELATING TO PET AMYLOID AND CSF AMYLOID AND TAU (2016) (0)
- Oligodendrocyte Lineage Transcription Factor 2 role in Alzheimer's disease: association and expression analysis (2011) (0)
- Natural vegan meal replacement: metabolic and oxidative modulation on overweight subjects (2017) (0)
- LONGITUDINAL ASSOCIATION BETWEEN APATHYAND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA STRUCTURAL MRI TELL ABOUT A/T/N STAGING? (2019) (0)
- TREM2 GENETIC VARIABILITY IN PATIENTS WITH ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (2014) (0)
- Erratum to: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (2016) (0)
- SORL1 gene and convertion from mild cognitive impairment to Alzheimer’s disease (2011) (0)
- Annamaria Confaloni PhD (2011) (0)
- Corrigendum (2010) (0)
- APOE in differents forms of MCI (2008) (0)
- ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN) (2014) (0)
- Novel therapies for Alzheimer's disease: Potentially disease modifying drugs (2009) (0)
- Association analysis and influence between ORL1 rs1050283 variant and miRNA 369-3p in patients with Alzheimer’s disease. (2010) (0)
- Faculty Opinions recommendation of Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. (2012) (0)
- P.1.015 Selective methylation of brain derived neurotrophic factor gene promoter in bipolar disorder: differences between patients and controls (2012) (0)
- Repetitive element hypermethylation in multiple sclerosis patients (2016) (0)
- Transcription factor Sp1 is regulated by hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer’s disease (2012) (0)
- Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage (2022) (0)
- MSJ852092_supplementary_material – Supplemental material for T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients (2019) (0)
- P.1.a.008 Increased DNA methylation of the prodynorphin gene promoter in peripheral blood mononuclear cells from patients with bipolar disorder (2013) (0)
- Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia (2019) (0)
- ANALYSIS OF IL-33 AND ITS DECOY RECEPTOR SST2 IN ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT PATIENTS (2019) (0)
- Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
- Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging (2020) (0)
- The expression pattern of GDF15 in human brain changes during aging and in Alzheimer’s disease (2023) (0)
- Rare missense variant (R251G) on APOE counterbalances the Alzheimer’s disease risk associated with APOE‐ε4 (2022) (0)
- Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis (2011) (0)
- Successful treatment of macular retinoblastoma with superselective ophthalmic artery infusion (2012) (0)
- Ask the Experts: Progress in diagnosing frontotemporal lobar dementia (2012) (0)
- Neurofilament light chain: a biomarker for disease onset and survival in genetic frontotemporal dementia (2016) (0)
- A new method to discriminate among different memory disorders (2005) (0)
- Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (2023) (0)
- Abstract Title: Corneal Involvement in Graves Ophthalmopathy: An in vivo Confocal (2009) (0)
- A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study (2021) (0)
- Spinal cord infarction: a rare cause of admission to Internal Medicine Departments but a condition with relevant systemic complications (2013) (0)
- A case of Bipolar Disorder developing into an Atypical Parkinsonism and presenting with Frontotemporal Asymmetrical Brain Degeneration. A TREDEM Registry Case Report. (2019) (0)
- P.197 On the role of DNA methylation and hydroxymethylation in Obsessive Compulsive Disorder: focus on BDNF (2019) (0)
- ORL1 rs1050283: association analysis and influence on miRNA 369-3p binding in patients with Alzheimer's disease (2010) (0)
- Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales (2023) (0)
- Modulation of RAS and PI3-AKT pathway by Stavudine (d4T) in PBMC of Alzheimer’s Disease Patients (2020) (0)
- Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis. (2022) (0)
- Increased intrathecal chemokine synthesis in MCI and mild AD patients. Implications in the pathogenesis and relevance for early diagnosis (2005) (0)
- Role of OLR1 and Its Regulating hsa-miR369-3p in Alzheimer’s Disease: Genetic and Expression Analysis (2011) (0)
- The leukocyte expression of CD36 is reduced in patients with Alzheimer disease and in early phase of dementia (2005) (0)
- P2-138 Chemokine serum levels in mild cognitive impairment as Alzheimer’s disease early biomarkers (2006) (0)
- Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (2015) (0)
- Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there? (2021) (0)
- Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative (2020) (0)
- Vascularized vitreous seeding regression following systemic and intravitrealchemotherapy for advanced "late" retinoblastoma (2014) (0)
- Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia (2021) (0)
- P.2.e.017 DNA methylation is selectively altered in bipolar disorder and linked to DNA methyltransferases and histone deacetylases mRNAs levels (2012) (0)
- SQSTM1 gene sequencing in frontotemporal lobar degeneration and Amyotrophic Lateral Sclerosis (2012) (0)
- I120 THE ARGENTINE EXPERIENCE: PROGRAM OF HEALTH CARE FOR VICTIMS OF SEXUAL ASSAULT IN PUBLIC HOSPITALS IN BUENOS AIRES (2012) (0)
- Feasibility of implementing a standard cognitive assessment in Italian academic and non‐academic memory clinics (2022) (0)
- Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers. (2022) (0)
- Cerebrospinal fluid glutamate changes in functional movement disorders (2020) (0)
- P1-177 Total folate levels in Alzheimer disease and other forms of degenerative cognitive decline (2006) (0)
- Pattern of progression in MAPT‐related frontotemporal dementia: Results from the GENFI study (2021) (0)
- Erratum: The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers (Alzheimer's and Dementia (2011) 7 (386-395)) (2011) (0)
- Urea cycle and Alzheimer's disease (2009) (0)
- P4-065 Glu298ASP polymorphism of the E-NOS gene and homocysteine levels in patients with Alzheimer's disease and vascular dementia (2004) (0)
- Lack of Association between the GPR3 Gene and the Risk for Alzheimer's Disease (2011) (0)
- Poster Session‐Saturday (2016) (0)
- Vascular risk factors do not individually effect risk of conversion of mild cognitive impairment to dementia. (2009) (0)
- Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis. (2019) (0)
- IN GENETIC FRONTOTEMPORAL DEMENTIA, FUNCTIONAL NETWORK EFFICIENCY IS MAINTAINED UNTIL THE ONSET OF SYMPTOMS: EVIDENCE FOR FUNCTIONAL RESILIENCE TO STRUCTURAL CHANGE (2017) (0)
- CHMP5 and BAG1 are protective factors for sporadic Frontotemporal Lobar Degeneration (2010) (0)
- A sporadic case of Progressive Non-Fluent Aphasia (PNFA) caused by a novel progranulin mutation (2011) (0)
- Faculty Opinions recommendation of Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. (2008) (0)
- Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort (2023) (0)
- Faculty Opinions recommendation of Variant of TREM2 associated with the risk of Alzheimer's disease. (2013) (0)
- Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales (2018) (0)
- P3-217: Genetic and functional analysis of progranulin gene variants in patients with Alzheimer's disease (2008) (0)
- Prevalence of ApoE-e2 allele in different kinds of dementia (2007) (0)
- P1-329 Presenilin-1 mutation E318G in Italian population: Genetic screening and effect on beta amyloid metabolism in human fibroblasts (2006) (0)
- Faculty Opinions recommendation of The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. (2008) (0)
- Drusen-like deposits in young adults affected by Systemic Lupus Erythematosus (2016) (0)
- Distinct patterns of brain atrophy in genetic frontotemporal dementia: visual rating scales in the GENFI cohort (2016) (0)
- Outcome of retinoblastoma patients treated according to the University Hospital of Siena guidelines (2017) (0)
- Supraselective intraarterial melphalan as the primary treatment for advanced retinoblastoma in older children (2011) (0)
- Frontotemporal dementia and parkinsonism linked to chromosome 17 granulin: Clinical and pathologic study of a patient from a new pedigree (2015) (0)
- Measurement of the Retina and Choroid Diffusion Coefficients During TTT (2007) (0)
- LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA (2019) (0)
- Inflammation in Dry Eye Associated With Rheumatoid Arthritis: Immunoenzymatic and in vivo Confocal Study (2009) (0)
- Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia (2022) (0)
- ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN) (2014) (0)
- Low dose-topiramate-induced acute bilateral reversible glaucoma : a case report (2009) (0)
- P1-444 Low doses of memantine are effective in reducing behavioral symptoms in AD patients (2006) (0)
- Atrophy patterns in sporadic and genetic behavioral variant frontotemporal dementia reflect brain network architecture (2021) (0)
- Dissecting frontotemporal dementia: Correlations between neuropsychiatric symptoms and neuropathology (2020) (0)
- Plasma Neuro fi lament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration (0)
- IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment (2020) (0)
- Grey matter differences in genetic frontotemporal dementia: Results from the genfi study (2015) (0)
- Faculty Opinions recommendation of Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. (2010) (0)
- EP 4102 A 16-year network organization of memory clinics in the North of France : new patients characteristics over time (2014) (0)
- Recurrent Head Trauma: A Trigger of the Alzheimer Cascade or the Cause of an Independent Pathologic Entity? - An Explicative Case of Chronic Traumatic Encephalopathy Mimicking Alzheimer's Disease (2017) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- Lack of Association between the GPR 3 Gene and the Risk for Alzheimer ’ s Disease (2011) (0)
- hnRNP-A1 rs7967622 is a risk factor for sporadic Frontotemporal Lobar degeneration but not for Alzheimer’s disease (2010) (0)
- RANDOMISED PILOT STUDY ON THE FEASIBILITY OF ENOXAPARIN TREATMENT IN ALZHEIMER ' S DISEASE (2011) (0)
- The Capacity Of Cerebrospinal Fluid To Promote Cholesterol Efflux Through Abca1 And Abcg1 Is Specifically Impaired In Alzheimer’S Disease Patients (2019) (0)
- Gender-specific influence of the chromosome 16 gene cluster on the susceptibility to multiple sclerosis (2007) (0)
- NOVEL CSF BIOMARKERS DISCRIMINATING FTLD-TDP FROM NON-DEMENTED CONTROLS (2016) (0)
- OLR1 and its regulatory miR-369-3p : genetics and expression analysis (2011) (0)
- Unravelling the association between amyloid-pet and CSF biomarkers: Who really deserves an A +? (2021) (0)
- P.1.a.016 Progranulin gene variability could decrease the risk to develop bipolar disorder and schizophrenia (2012) (0)
- To perform a whole gene expression profiling in peripheral cells from patients with MCI, Prodromal AD (MCI with AD CSF profile) and AD compared with controls (2014) (0)
- P1-221 Association between dementia and cancer (2006) (0)
- New Perspectives for the Treatment of Alzheimer’s Disease~!2008-10-07~!2008-10-30~!2008-11-26~! (2008) (0)
- Biomarkers for Early Diagnosis of Alzheimer's Disease (2008) (0)
- Patterns of longitudinal neuroanatomical change in genetic FTD: results from the Genetic FTD Initiative (GENFI) (2016) (0)
- Corrigendum to Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. (2012) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- Neuropsychiatric symptoms in the genetic frontotemporal dementia initiative (GENFI) cohort (2016) (0)
- Corrigendum to “Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study” [Neurobiology of Aging Volume 108, December 2021, Pages 155–167] (2022) (0)
- Late intraocular relapses in retinoblastoma (2016) (0)
- STAVUDINE INHIBITS INFLAMMASOME ACTIVATION MOLECULAR INHIBITOR IN PERIPHERAL-MONOCYTES OF AD PATIENTS (2018) (0)
- A NOVEL MUTATION IN PROGRANULIN GENE IN BEHAVIOURAL VARIANT FRONTO-TEMPORAL DEMENTIA (2014) (0)
- Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect. (2023) (0)
- P.002 Exosomal miR-204-5 and miR-632 in CSF are candidate biomarkers for frontotemporal dementia: a GENFI study (2018) (0)
- miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia (2022) (0)
- Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia (2023) (0)
- 1-12-04 Network of proinflammatory, chemotactic and inhibitory cytokines from amyloid deposition and phagocyte activation in Alzheimer's disease (1997) (0)
- DEFECTIVE MIRNA-223-MEDIATED REGULATION OF NLRP3 INFLAMMASOME ACTIVATION IN ALZHEIMER’S DISEASE (2019) (0)
- KIF24 W218L single nucleotide polymorphism is a risk factor for sporadic frontotemporal lobe degeneration (2009) (0)
- Association of genetic markers with the presence of cerebrospinal fluid oligoclonal bands in the Italian population (2012) (0)
- CEREBRAL PERFUSION AS AN IMAGING BIOMARKER OF PRESYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA: PRELIMINARY RESULTS FROM THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) (2016) (0)
- Language impairment in the genetic forms of behavioural variant frontotemporal dementia (2022) (0)
- NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration (2008) (0)
- A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease (2022) (0)
- Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes (2019) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) (2022) (0)
- Faculty Opinions recommendation of Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. (2011) (0)
- Frontotemporal lobardegeneration: current knowledge and future challenges (2012) (0)
- P1-207: APOE alleles distribution in different forms of mild cognitive impairment (2008) (0)
- P3-167 Absence of mutations in TREM-2 coding region in early onset dementia (2006) (0)
- The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort (2021) (0)
- The Italian dementia with lewy bodies study group (DLB-SINDEM): A multicenter survey on the accuracy and the prevalence of DLB diagnosis (2021) (0)
- Increased neurofilament light chain correlates with decreased white matter integrity in presymptomatic and symptomatic granulin carriers (2016) (0)
- Presymptomatic cerebral perfusion biomarker changes in genetic frontotemporal dementia: results from the GENetic Frontotemporal dementia Initiative (GENFI) (2016) (0)
- Screening of the PFN1 gene in sporadic ALS and in FTD (2013) (0)
- The diagnostic pathway embolism: from the Emergency Department to the Internal Medicine Unit (2016) (0)
- Corneal Involvement in Graves Ophthalmopathy: An in vivo Confocal Study (2009) (0)
- Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales (2022) (0)
- Validation of the Italian Addenbrooke’s cognitive examination revised (ACE-R) as a screening test (2012) (0)
- Erratum: Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (Scientific reports (2017) 7 1 (8899)) (2018) (0)
- TITLE PAGE Title: Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers Running head: Cortical thinning in C9orf72 expansion carriers (2020) (0)
- Differential synaptic marker involvement in the different genetic forms of frontotemporal dementia (2021) (0)
- Association of the CBLB gene with MS: new evidence from a replication study in an Italian population (2010) (0)
- IN GENETIC FRONTOTEMPORAL DEMENTIA, FUNCTIONAL NETWORK EFFICIENCY IS MAINTAINED UNTIL THE ONSET OF SYMPTOMS: EVIDENCE FOR FUNCTIONAL RESILIENCE TO STRUCTURAL CHANGE (2017) (0)
- P2‐177: WITHDRAWN (2018) (0)
- Faculty Opinions recommendation of Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. (2009) (0)
- OP-BRAI180237 2895..2907 (2018) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study (2022) (0)
- Underweight accelerates progression of mind cognitive impairment to dementia (2011) (0)
- Genetic risk factors and role of immune dysfunction in FTLD (2019) (0)
- Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes (2022) (0)
- Detecting clinical progression from abnormal regional brain volumes at baseline in genetic frontotemporal dementia: A GENFI study (2021) (0)
- C0600: New Oral Anticoagulants in Patients Affected by Atrial Fibrillation with History of Intracranial Hemorrhage (2014) (0)
- rs5848 variant influences GRN mRNA levels in patients with Alzheimer's Disease. (2009) (0)
- Causal frontotemporal lobar degeneration mutations: A novel mutation in MAPT associated with non-fluent progressive aphasia phenotype (2011) (0)
- Dementia: not only Alzheimer's disease, an eye on frontotemporal dementia. (2013) (0)
- P.1.019 Does the progranulin gene variability decrease the risk to develop bipolar disorder and schizophrenia? (2012) (0)
- Genetics and molecular biology of alzheimer's disease and frontotemporal lobar degeneration: Analogies and differences (2011) (0)
- Corrigendum : Cerebral perfusion changes in presymptomaticgenetic frontotemporal dementia: a GENFIstudy (Brain (2019) DOI: 10.1093/brain/awz039) (2019) (0)
- Gender-related genetic and biochemical differences: influence on susceptibility and course of multiple sclerosis (2009) (0)
- Neurophysiological Profile, Walking Performance Tests and Self-Reported Questionnaires in Spastic Patients with MS: A Pilot Study (2016) (0)
- Chromosome 9 and sporadic Frontotemporal Lobar Degeneration: KIF24, but not UBAP1, is a risk factor in Italian population (2010) (0)
- Loss of cobalamin-mediated regulation leads to decreased EGF and increased soluble CD40 levels in cerebrospinal fluid of patients with multiple sclerosis (2009) (0)
- Teaching NeuroImage: Crowned Dens Syndrome (2022) (0)
- Risk of immune reconstitution inflammatory syndrome (IRIS) in natalizumab-associated PML (2015) (0)
- C9ORF72 Hexanucleotide Repeat Expansion in a Cohort of Italian Patients Affected by Amyotrophic Lateral Sclerosis with and without Frontotemporal Dementia (P05.162) (2012) (0)
- PRESYMPTOMATIC WHITE MATTER INTEGRITY LOSS IN FAMILIAL FRONTOTEMPORAL DEMENTIA IN THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) COHORT: A MULTI-CENTRE, CROSS-SECTIONAL, DIFFUSION TENSOR IMAGING STUDY (2017) (0)
- Progranulin gene mutation scanning in Multiple Sclerosis patiens with cognitive impairment. (2008) (0)
- Association study of the ADAM12 and SH3MD1 genes with the risk of developing Alzheimer's disease (2009) (0)
- FRONTO-SUBCORTICAL HYPOPERFUSION IN PRESYMPTOMATIC FTD IS ASSOCIATED WITH BEHAVIORAL MEASURES, BUT NOT COGNITIVE DEFICITS: THE GENFI STUDY (2017) (0)
- Selectin gene cluster genetic variation: association study in two independent multiple sclerosis populations. (2008) (0)
- Transcriptional regulation of BDNF and oxytocin receptor genes in Obsessive Compulsive Disorder (2018) (0)
- Cognitive composites for genetic frontotemporal dementia: GENFI-Cog (2022) (0)
- Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 13 (2003) (0)
- Lag-time in Alzheimer’s disease patients: a potential plasmatic oxidative stress marker associated with ApoE4 isoform (2019) (0)
- Retinal Findings with Multimodal Imaging in Primary Intraocular Lymphoma (2012) (0)
- P.2.e.028 Selective DNA methylation of brain derived neurotrophic factor promoter and nociceptin gene in bipolar disorder (2011) (0)
- P.3.004 Possible interplay between BDNF and dynorphin in bipolar disorder: role of epigenetic mechanisms (2013) (0)
- Shorter disease duration in females with sporadic frontotemporal dementia (2022) (0)
- Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study (2022) (0)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Daniela Galimberti?
Daniela Galimberti is affiliated with the following schools:
